BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35450818)

  • 1. Mitochondrial micropeptide STMP1 promotes G1/S transition by enhancing mitochondrial complex IV activity.
    Sang Y; Liu JY; Wang FY; Luo XY; Chen ZQ; Zhuang SM; Zhu Y
    Mol Ther; 2022 Aug; 30(8):2844-2855. PubMed ID: 35450818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis.
    Xie C; Wang FY; Sang Y; Chen B; Huang JH; He FJ; Li H; Zhu Y; Liu X; Zhuang SM; Fang JH
    Cancer Res; 2022 Jul; 82(13):2431-2443. PubMed ID: 35544764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity.
    Xiao MH; Lin YF; Xie PP; Chen HX; Deng JW; Zhang W; Zhao N; Xie C; Meng Y; Liu X; Zhuang SM; Zhu Y; Fang JH
    Mol Ther; 2022 Feb; 30(2):714-725. PubMed ID: 34478872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00998-encoded micropeptide SMIM30 promotes the G1/S transition of cell cycle by regulating cytosolic calcium level.
    Yang JE; Zhong WJ; Li JF; Lin YY; Liu FT; Tian H; Chen YJ; Luo XY; Zhuang SM
    Mol Oncol; 2023 May; 17(5):901-916. PubMed ID: 36495128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial micropeptide Stmp1 promotes retinal cell differentiation.
    Zheng X; Guo Y; Zhang R; Chen H; Liu S; Qiu S; Xiang M
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):79-86. PubMed ID: 36368158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
    Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
    Sun J; Wang X; Shen Q; Wang M; Chen S; Zhang X; Huang Y; Zhang Z; Li W; Yuan Y; Huang Z
    Cell Oncol (Dordr); 2022 Dec; 45(6):1187-1202. PubMed ID: 36327092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma.
    Xiang Y; Yang Y; Lin C; Wu J; Zhang X
    J Physiol Biochem; 2020 Feb; 76(1):123-134. PubMed ID: 31994011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
    Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
    BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation.
    Liu JY; Chen YJ; Feng HH; Chen ZL; Wang YL; Yang JE; Zhuang SM
    Cell Death Dis; 2021 Oct; 12(11):970. PubMed ID: 34671012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
    Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma.
    Liu Y; Yao Y; Liao B; Zhang H; Yang Z; Xia P; Jiang X; Ma W; Wu X; Mei C; Wang G; Gao M; Xu K; GongYe X; Cheng Z; Jiang P; Chen X; Yuan Y
    Int J Biol Sci; 2022; 18(10):4071-4087. PubMed ID: 35844791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 15. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
    Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
    Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
    J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
    Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
    Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K
    Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
    Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
    Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.